Literature DB >> 32817088

Transcriptional Downregulation of a Type III Secretion System under Reducing Conditions in Bordetella pertussis.

Masataka Goto1, Tomoko Hanawa2, Akio Abe1, Asaomi Kuwae3.   

Abstract

Bordetella pertussis uses a type III secretion system (T3SS) to inject virulence proteins into host cells. Although the B. pertussis T3SS was presumed to be involved in host colonization, efficient secretion of type III secreted proteins from B. pertussis has not been observed. To investigate the roles of type III secreted proteins during infection, we attempted to optimize culture conditions for the production and secretion of a type III secreted protein, BteA, in B. pertussis We observed that B. pertussis efficiently secretes BteA in ascorbic acid-depleted (AsA-) medium. When L2 cells, a rat lung epithelial cell line, were infected with B. pertussis cultured in the AsA- medium, BteA-dependent cytotoxicity was observed. We also performed an immunofluorescence assay of L2 cells infected with B. pertussis Clear fluorescence signals of Bsp22, a needle structure of T3SS, were detected on the bacterial surface of B. pertussis cultured in the AsA- medium. Since ascorbic acid is known as a reducing agent, we cultured B. pertussis in liquid medium containing other reducing agents such as 2-mercaptoethanol and dithioerythritol. Under these reducing conditions, the production of type III secreted proteins was repressed. These results suggest that in B. pertussis, the production and secretion of type III secreted proteins are downregulated under reducing conditions.IMPORTANCE The type III secretion system (T3SS) of Bordetella pertussis forms a needlelike structure that protrudes from the bacterial cell surface. B. pertussis uses a T3SS to translocate virulence proteins called effectors into host cells. The culture conditions for effector production in B. pertussis have not been investigated. We attempted to optimize culture medium compositions for producing and secreting type III secreted proteins. We found that B. pertussis secretes type III secreted proteins in reducing agent-deprived liquid medium and that BteA-secreting B. pertussis provokes cytotoxicity against cultured mammalian cells. These results suggest that redox signaling is involved in the regulation of B. pertussis T3SS.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Bordetellazzm321990; type III secretion system

Mesh:

Substances:

Year:  2020        PMID: 32817088      PMCID: PMC7549366          DOI: 10.1128/JB.00400-20

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

1.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

2.  Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 3.  Regulatory mechanisms of thiol-based redox sensors: lessons learned from structural studies on prokaryotic redox sensors.

Authors:  Sang Jae Lee; Dong-Gyun Kim; Kyu-Yeon Lee; Ji Sung Koo; Bong-Jin Lee
Journal:  Arch Pharm Res       Date:  2018-05-17       Impact factor: 4.946

4.  Bordetella effector BopN is translocated into host cells via its N-terminal residues.

Authors:  Akio Abe; Ryutaro Nishimura; Asaomi Kuwae
Journal:  Microbiol Immunol       Date:  2017-06       Impact factor: 1.955

5.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Adaptation of Bordetella pertussis to the Respiratory Tract.

Authors:  Lucille F van Beek; Daan de Gouw; Marc J Eleveld; Hester J Bootsma; Marien I de Jonge; Frits R Mooi; Aldert Zomer; Dimitri A Diavatopoulos
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

8.  Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo.

Authors:  Bob Medhekar; Ruchi Shrivastava; Seema Mattoo; Mari Gingery; Jeff F Miller
Journal:  Mol Microbiol       Date:  2008-12-05       Impact factor: 3.501

9.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.

Authors:  Hyun-Ja Han; Asaomi Kuwae; Akio Abe; Yoshichika Arakawa; Kazunari Kamachi
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

View more
  1 in total

Review 1.  Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host.

Authors:  Thomas Belcher; Violaine Dubois; Alex Rivera-Millot; Camille Locht; Françoise Jacob-Dubuisson
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.